Atorvastatin konupora

Whakaahuatanga Poto:

Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP
Atorvastatin konupora Hypercholesterolemia Roto-Whare/CEP 29057 CEP 2015-034


Taipitopito Hua

Tohu Hua

WHAKAMAHI HUA

Papamuri

Ko te Atorvastatin Calcium he aukati kaha o te HMG-CoA reductase me te uara IC50 o te 150 nM[1].
Ko te HMG-CoA reductase te whākōkī matua o te ara mevalonate e whakaputa cholesterol.Ko te HMG-CoA te whākōkī whakaheke reiti, ā, he mea nui mō te whakaheke i ngā taumata cholesterol toto.Ko te HMG-CoA reductase kei roto i te reticulum endoplasmic, e waru nga rohe whakawhiti.Ka taea e nga aukati o te HMG-CoA reductase te whakakorikori i te LDL (te iti kiato lipoprotein) te whakaputa korero i roto i te ate.Ka arahi ki te whakanui ake i nga taumata catabolism o te LDL plasma me te whakaheke i te kukū o te cholesterol plasma he tohu nui mo te atherosclerosis.Ko te HMG-CoA reductase he mahi nui ki te whakahiato cholesterol.Ko HMG-CoA te whainga mo nga raau taero whakaheke cholesterol.Ko te HMG-CoA reductase he whākōkī nui mō te whanaketanga.Ko te ngohe o te HMG-CoA reductase e pa ana ki nga ngoikoretanga o te heke o nga pūtau iroriki.Ko te aukati i tana mahi ka arahi i te whakaheke toto i roto i te cerebral[1].
Ko te Atorvastatin he aukati HMG-CoA reductase me te uara IC50 o te 154 nM.He whai hua ki te rongoa i etahi dyslipidemias me te hypercholesterolemia[1].Ko te maimoatanga o te Atorvastatin i te 40 mg ka whakaheke i te cholesterol katoa o te 40% i muri i te 40 ra.[1]Ka whakamahia ano ki te rongoa i nga turoro mate pukupuku, mate whiu ranei me nga taumata cholesterol noa.[2]Ka whakahekehia ano hoki e te Atorvastatin te apheresis o te lipoprotein kiato iti i roto i nga turoro ma te akiaki i nga korero a nga kaiwhiwhi LDL.
Ka whakakorikoria ki te maha o nga metabolites he mea nui mo te painga o nga mahi rongoa a CYP3A4 (cytochrome P450 3A4).[3]
Tohutoro:
[1].van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ: Te whai hua mo te wa roa me te haumaru o te atorvastatin i roto i te maimoatanga o te momo III kino me te dyslipidemia whakakotahi.Ngakau 2002, 88(3):234-238.
[2].Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT et al: Te aukati i nga huihuinga coronary me te whiu me te atorvastatin i nga turoro hypertensive he toharite, he iti ake ranei. -te tohenga o te cholesterol, i roto i te Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): he whakawakanga whakahaere matapōkeretia.Lancet 2003, 361(9364):1149-1158.
[3].Lennernas H: pharmacokinetics haumanu o te atorvastatin.Clin Pharmacokinet 2003, 42 (13): 1141-1160.

Hanganga matū

Atorvastatin-Calcium

Tiwhikete

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

TE WHAKAMAHI KOI

Quality management1

Tono18Ko nga kaupapa Aromātai Tauritenga Kounga kua whakaaetia4, a6kei te whakamanahia nga kaupapa.

Quality management2

Ko te punaha whakahaere kounga teitei o te ao kua whakatakoto he turanga pakari mo nga hoko.

Quality management3

Ko te tirotiro i te kounga ka haere i roto i te huringa ora katoa o te hua ki te whakarite i te kounga me te hua rongoa.

Quality management4

Ko te roopu Whakahaere Whakahaere Ngaio e tautoko ana i nga hiahia kounga i te wa o te tono me te rehitatanga.

WHAKAMAHI WHAKATANGA

cpf5
cpf6

Korea Countec Pounamu Whakapai Raina

cpf7
cpf8

Taiwan CVC Pounamu Packaging Raina

cpf9
cpf10

Itari CAM Board Packaging Raina

cpf11

Miihini Whakakii Fette Tiamana

cpf12

Hapanihi Viswill Tablet Detector

cpf14-1

Rūma Whakahaere DCS

HOANI

Te mahi tahi o te ao
International cooperation
Te mahi tahi a-whare
Domestic cooperation

  • Tōmua:
  • Panuku:

  • Tuhia to korero ki konei ka tukuna mai ki a matou

    Nga waahanga hua